Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Eye Pain Clinical Trial

Official title:
Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

Status Completed

Clinical Trial Summary

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

Clinical Trial Description

The primary objective of this study is to evaluate the systemic pharmacokinetics (PK) of LE (loteprednol etabonate ophthalmic gel), 0.38% in normal healthy volunteer subjects at least 18 years of age and with a normal ophthalmic history. Systemic PK will be assessed in this study after a single dose and after 2 weeks of daily BID dosing. ;

Study Design

Related Conditions & MeSH terms

Eye Pain

Clinical Trial Details

NCT number	NCT03063489
Study type	Interventional
Source	Valeant Pharmaceuticals International, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	February 2015
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05531643` - Pilot Study of TENS for Ocular Pain	N/A
Completed	`NCT05832996` - Cool vs Room-temperature Artificial Tears	Phase 4
Recruiting	`NCT05931250` - Alternating and Direct Current Stimulation for Neuropathic Eye Pain	N/A
Recruiting	`NCT01824927` - Pain Expression in the Perioperative Period of Cataract Surgery	N/A
Completed	`NCT04648085` - Effect of Trigeminal Nerve Stimulation on Corneal Nerves and Chronic Ocular Pain	N/A
Recruiting	`NCT03652415` - DRy Eye Outcome and Prescription Study